CM
Castleark Management Portfolio holdings
AUM
$3.33B
This Quarter Return
-4.29%
1 Year Return
+37.9%
3 Year Return
+222.09%
5 Year Return
+481.09%
10 Year Return
+2,703.89%
AUM
$2.89B
AUM Growth
+$2.89B
(+0.64%)
Cap. Flow
+$213M
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
40.26%
Holding
355
New
72
Increased
84
Reduced
52
Closed
75
Top Buys
| 1 |
CastleArk Large Growth ETF
CARK
|
$295M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
$56.5M |
| 3 |
Invesco QQQ Trust
QQQ
|
$31.2M |
| 4 |
Eli Lilly
LLY
|
$30.5M |
| 5 |
Accenture
ACN
|
$18.5M |
Top Sells
| 1 |
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
$56.9M |
| 2 |
Apollo Global Management
APO
|
$37.5M |
| 3 |
Broadcom
AVGO
|
$35M |
| 4 |
Microsoft
MSFT
|
$24.1M |
| 5 |
Apple
AAPL
|
$16.4M |
Sector Composition
| 1 | Technology | 25.31% |
| 2 | Healthcare | 10.19% |
| 3 | Financials | 9.99% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Exxon Mobil
XOM
$477B
| – | – |
-36,610
| Closed | -$3.94M |
|
352
Astera Labs
ALAB
$29.4B
| – | – |
-2,750
| Closed | -$364K |
|
353
GE Vernova
GEV
$157B
| – | – |
-1,130
| Closed | -$372K |
|
|
ITCI
354
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-50,010
| Closed | -$4.18M |
|
|
ENLC
355
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| – | – |
-152,400
| Closed | -$2.16M |
|